WP
APTO

Woodline Partners’s Aptose Biosciences, Inc. APTO Stock Holding History

Woodline Partners’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-490
Closed -$481K – 834
2021
Q3 		$481K Sell
490
-32
-6% -$40K 0.01% 552
2021
Q2 		$780K Sell
522
-4,408
-89% -$9.6M 0.01% 448
2021
Q1 		$13.3M Buy
4,930
+2,792
+131% +$5.54M 0.29% 93
2020
Q4 		$4.21M Sell
2,138
-1,490
-41% -$3.5M 0.11% 165
2020
Q3 		$9.79M Buy
3,628
+2,294
+172% +$5.72M 0.32% 86
2020
Q2 		$3.79M Buy
1,334
+1,212
+993% +$3.91M 0.15% 122
2020
Q1 		$327K Buy
+122
New +$364K 0.02% 135

Other funds holding APTO

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SMH
Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Woodline Partners's APTO Position: Q4 2021 in Review

Woodline Partners sold out of Aptose Biosciences, Inc. (APTO) in Q4 2021, closing a stake of 490 shares — an estimated $481K sold.

Woodline Partners first reported a position in APTO in Q1 2020 and held it in 7 quarters. The position peaked at $13.3M in Q1 2021. 58 funds tracked by Wall St. Rank hold APTO as of Q4 2021.

  • Woodline Partners reported no remaining Aptose Biosciences, Inc. position as of Q4 2021 after selling out during the quarter.
  • Woodline Partners sold 490 Aptose Biosciences, Inc. shares in Q4 2021, an estimated $481K.
  • Woodline Partners first reported a position in Aptose Biosciences, Inc. in Q1 2020 and held it in 7 quarters.
  • Woodline Partners's Aptose Biosciences, Inc. position peaked at $13.3M in Q1 2021.
  • 58 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q4 2021.

Based on Woodline Partners's 13F filing for Q4 2021, filed 14 Feb 2022.